Theratechnologies (THTX)
(Delayed Data from NSDQ)
$1.22 USD
-0.04 (-3.17%)
Updated Jun 7, 2024 03:59 PM ET
After-Market: $1.22 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.22 USD
-0.04 (-3.17%)
Updated Jun 7, 2024 03:59 PM ET
After-Market: $1.22 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth C Momentum A VGM
Zacks News
Theratechnologies (THTX) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Theratechnologies (THTX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Theratechnologies (THTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Theratechnologies (THTX) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Theratechnologies (THTX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Theratechnologies (THTX) Enters Overbought Territory
by Zacks Equity Research
Theratechnologies (THTX) has moved higher as of late, but there could definitely be trouble on the horizon for this company